Wednesday, August 17, 2022 3:17:51 PM
Then the hard fact is that people will view Regen as a hit and run kind of stock, simple because things go so slow & that most of the Pharmaceutical Co's don't make it past the first stage in the Clinical trials? Some have good products but don't have the money to go through the full Clinical Trial phase, though the NR2F6 Chemistry is unlike the more invasive chemistries that require more time and money!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM